Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

Description

This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.

Conditions

Low Grade Ovarian Serous Adenocarcinoma, Malignant Ovarian Neoplasm, Ovarian Carcinoma, Primary Peritoneal Carcinoma, Primary Peritoneal Low Grade Serous Adenocarcinoma, Psammocarcinoma

Study Overview

Study Details

Study overview

This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.

Data Collection for Patients With Low Grade Ovarian Carcinoma

Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

Condition
Low Grade Ovarian Serous Adenocarcinoma
Intervention / Treatment

-

Contacts and Locations

Houston

M D Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:
  • * Ovarian tumor of low malignant potential
  • * Low-grade serous carcinoma of the ovary
  • * Primary peritoneal tumor of low malignant potential
  • * Low-grade serous carcinoma of the peritoneum
  • * Psammocarcinoma

Ages Eligible for Study

to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

David M Gershenson, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2035-05-01